FDA Inspection 622905 — Vitalant

Vitalant — FEI 2577640

The FDA completed an inspection of Vitalant on October 27, 2009 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 27, 2009
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pittsburgh, PA (United States)

Citations

IDCFRDescription
3121 CFR 606.20(b)Qualifications of responsible personnel
6721 CFR 606.65(e)Following manufacturer's instructions
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs